MX2011013452A - Tratamiento de cancer basado en exosomas. - Google Patents
Tratamiento de cancer basado en exosomas.Info
- Publication number
- MX2011013452A MX2011013452A MX2011013452A MX2011013452A MX2011013452A MX 2011013452 A MX2011013452 A MX 2011013452A MX 2011013452 A MX2011013452 A MX 2011013452A MX 2011013452 A MX2011013452 A MX 2011013452A MX 2011013452 A MX2011013452 A MX 2011013452A
- Authority
- MX
- Mexico
- Prior art keywords
- cancer
- cells
- patient
- exosomes
- based treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 4
- 210000001808 exosome Anatomy 0.000 title abstract 4
- 210000004027 cell Anatomy 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000003306 harvesting Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Un método para tratar cáncer en un paciente comprende inmortalizar células B recolectadas del paciente por infección con virus de Epstein-Barr, transformar las células a una etapa latente, cultivar las células en la presencia de un antígeno de cáncer, recolectar los exosomas liberados de las células, administrar los exosomas al paciente. De manera alternativa, los exosomas recolectados se cargan con antígeno de cáncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0900904 | 2009-07-02 | ||
PCT/EP2010/003946 WO2011000551A1 (en) | 2009-07-02 | 2010-07-02 | Exosome based treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011013452A true MX2011013452A (es) | 2012-04-30 |
Family
ID=42989304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011013452A MX2011013452A (es) | 2009-07-02 | 2010-07-02 | Tratamiento de cancer basado en exosomas. |
Country Status (14)
Country | Link |
---|---|
US (1) | US8932855B2 (es) |
EP (1) | EP2448595B1 (es) |
JP (1) | JP2012531391A (es) |
KR (1) | KR20120081972A (es) |
CN (2) | CN102470167A (es) |
AU (1) | AU2010268367B2 (es) |
BR (1) | BRPI1013957A2 (es) |
CA (1) | CA2766833A1 (es) |
IL (1) | IL217291A0 (es) |
IN (1) | IN2012DN00423A (es) |
MX (1) | MX2011013452A (es) |
RU (1) | RU2012103482A (es) |
WO (1) | WO2011000551A1 (es) |
ZA (1) | ZA201109226B (es) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2419144T (pt) | 2009-04-17 | 2019-09-16 | Univ Oxford Innovation Ltd | Composição para a administração de material genético |
US9266957B2 (en) | 2009-11-10 | 2016-02-23 | Mayo Foundation For Medical Education And Research | Methods and materials for treating renal cell carcinoma and glioblastoma multiforme |
WO2011097480A1 (en) | 2010-02-05 | 2011-08-11 | University Of Louisville Research Foundation, Inc. | Exosomal compositions and methods for the treatment of disease |
SG183579A1 (en) * | 2011-02-11 | 2012-09-27 | Agency Science Tech & Res | Methods of detecting therapeutic exosomes |
WO2013070324A1 (en) | 2011-11-07 | 2013-05-16 | University Of Louisville Research Foundation, Inc. | Edible plant-derived microvesicle compositions for diagnosis and treatment of disease |
GB201121070D0 (en) * | 2011-12-07 | 2012-01-18 | Isis Innovation | composition for delivery of biotherapeutics |
US20150079046A1 (en) * | 2012-04-03 | 2015-03-19 | Reneuron Limited | Stem cell microparticles |
US20150297639A1 (en) * | 2012-04-18 | 2015-10-22 | Rhode Island Hospital, A Lifespan-Partner | Treating cancer |
EP2687219A1 (en) * | 2012-07-18 | 2014-01-22 | Universität Duisburg-Essen | Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions |
US9950074B2 (en) | 2012-10-12 | 2018-04-24 | Georg-August-Universität Göttingen Stiftung Öffenlichen Rechts, Universitätsmedizin | Composition and delivery vehicle for active agents and methods therefor |
WO2014078272A1 (en) | 2012-11-13 | 2014-05-22 | Mayo Foundation For Medical Education And Research | Methods and materials for assessing immune system profiles |
RU2693088C2 (ru) | 2013-03-13 | 2019-07-01 | Чжун ЛИ | Микровезикула и способ ее получения |
US10500231B2 (en) | 2013-03-13 | 2019-12-10 | University Of Miami | Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids |
US20160058856A1 (en) * | 2013-04-05 | 2016-03-03 | Kyushu University, National University Corporation | Anti-tumor dna vaccine |
WO2014182761A1 (en) * | 2013-05-09 | 2014-11-13 | Mayo Foundation For Medical Education And Research | Treating patients based on immune subtypes |
GB201317887D0 (en) | 2013-10-09 | 2013-11-20 | Reneuron Ltd | Product |
CN103468642A (zh) * | 2013-09-23 | 2013-12-25 | 山西大学 | 一种分离细胞培养基中外泌体的方法 |
CN104726410B (zh) * | 2013-12-23 | 2019-09-17 | 浙江大学 | 一种具有免疫抑制功能的外排体及其应用 |
CN103816535B (zh) * | 2014-03-04 | 2015-02-18 | 中国人民解放军总医院第一附属医院 | 一种肿瘤疫苗及其制备方法 |
US20170035700A1 (en) * | 2014-04-11 | 2017-02-09 | University Of Louisville Research Foundation, Inc. | Coated edible plant-derived microvesicle compositions and methods for using the same |
CN104341530B (zh) * | 2014-10-28 | 2017-05-10 | 重庆沁涟生物医药科技股份有限公司 | Vnsak多肽及其应用 |
EP3353528B1 (en) | 2015-09-22 | 2023-11-29 | Trustees of Boston University | Multiplexed phenotyping of nanovesicles |
US11243215B2 (en) | 2016-01-14 | 2022-02-08 | The Regents Of The University Of California | 3D-exoquant method for the analysis of surface molecules and quantification of tissue-specific exosomes in biological fluids |
US11262359B2 (en) | 2016-02-05 | 2022-03-01 | NanoView Biosciences, Inc. | Detection of exosomes having surface markers |
WO2017189281A1 (en) * | 2016-04-27 | 2017-11-02 | The Regents Of The University Of Michigan | C3d cellular and acellular vaccines for the prevention and treatment of cancer |
CN105861430B (zh) * | 2016-04-29 | 2019-07-23 | 南京大学 | 一种外泌体、外泌体的制备方法及其在制备治疗脓毒症药物或者制剂中的应用 |
CA3002520A1 (en) * | 2016-09-30 | 2018-04-05 | Cellex Life Sciences, Incorporated | Compositions containing protein loaded exosome and methods for preparing and delivering the same |
CN108324735B (zh) * | 2017-01-20 | 2024-02-09 | 李莉 | 用于疾病治疗的胞外体制剂及其应用 |
AU2018243554B2 (en) * | 2017-03-31 | 2024-02-15 | Wisconsin Alumni Research Foundation | Generation of therapeutic cells using extracellular components of target organs |
US10815520B2 (en) | 2017-04-07 | 2020-10-27 | University Of Louisville Research Foundation, Inc. | Nanovesicles, methods, and systems for diagnosis and prognosis of cancer |
CN110770587B (zh) * | 2017-05-08 | 2023-10-20 | 拜克门寇尔特公司 | 用于裂解红细胞的组合物和方法 |
EP3438250B1 (en) | 2017-07-31 | 2022-12-07 | Rheinische Friedrich-Wilhelms-Universität Bonn | Cell derived extracellular vesicles for the treatment of diseases |
CA3082436A1 (en) * | 2017-11-16 | 2019-05-23 | Board Of Regents, The University Of Texas System | Methods for production of msc-derived exosomes |
CN107988153B (zh) * | 2017-12-15 | 2021-05-18 | 英科博雅生命科技有限公司 | 人脐带血间充质干细胞源分离外泌体的方法和使用的试剂 |
CN108587998B (zh) * | 2018-05-17 | 2021-05-18 | 浙江大学 | 一种外泌体、外泌体的制备方法及其在制备皮肤浅表性肿瘤的药物中的应用 |
CN108635372A (zh) * | 2018-05-17 | 2018-10-12 | 广东芙金干细胞再生医学有限公司 | 一种人间充质干细胞源外泌体的生物制剂的制备方法 |
CN108795852A (zh) * | 2018-06-27 | 2018-11-13 | 华中科技大学 | 一种人肌母细胞外泌体的制备方法、产品及其应用 |
US11162143B2 (en) | 2018-10-21 | 2021-11-02 | The University Of Kansas | Methods for generating therapeutic delivery platforms |
CN113195103A (zh) * | 2018-10-21 | 2021-07-30 | 堪萨斯大学 | 用于生成治疗递送平台的方法 |
CN111840528A (zh) * | 2020-06-17 | 2020-10-30 | 河北大学 | 外泌体联合免疫检查点阻断剂的肿瘤疫苗及其制备方法 |
KR102559516B1 (ko) * | 2020-08-31 | 2023-07-26 | 경희대학교 산학협력단 | 우유 엑소좀을 포함하는 갈색지방화 유도용 조성물 |
CN113960313B (zh) * | 2021-12-22 | 2022-04-12 | 上海思路迪医学检验所有限公司 | 一种外泌体alk融合蛋白磁免疫化学发光检测试剂盒 |
GB202212626D0 (en) * | 2022-08-31 | 2022-10-12 | Terasom S R O | Cancer vaccine |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1630229B1 (en) | 1994-04-22 | 2013-04-03 | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services | Melanoma antigens |
US7084239B1 (en) | 1997-10-08 | 2006-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Cancer peptides of NY-ESO-1/CAG-3 |
CA2331258C (en) * | 1998-06-12 | 2011-09-20 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Enhancement of b cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and ebv gp350/220 |
FR2785543B1 (fr) * | 1998-11-05 | 2003-02-28 | Inst Nat Sante Rech Med | Exosomes modifies et utilisations |
US20030211510A1 (en) | 1999-06-30 | 2003-11-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US20040241176A1 (en) | 2000-04-27 | 2004-12-02 | Ap Cells. Inc. | Method of producing membrane vesicles |
HUP0300772A3 (en) | 2000-07-28 | 2005-11-28 | Liponova Ag | Medicament for the immunotherapy of malignant tumours |
EP1306431B1 (en) | 2000-07-31 | 2008-03-19 | Green Peptide Co., Ltd. | Tumor antigen |
DE10360456A1 (de) | 2003-12-22 | 2005-07-28 | Vaecgene Biotech Gmbh | Tumorantigene und deren Verwendung |
CA2504279A1 (en) | 2005-04-15 | 2006-10-15 | University Of Saskatchewan | Materials and method of modulating the immune response using t helper-antigen presenting cells |
CN1322115C (zh) * | 2005-07-06 | 2007-06-20 | 清华大学 | 载有外源配体分子的胞外体及其制备方法与应用 |
-
2010
- 2010-07-02 MX MX2011013452A patent/MX2011013452A/es not_active Application Discontinuation
- 2010-07-02 CA CA2766833A patent/CA2766833A1/en not_active Abandoned
- 2010-07-02 KR KR1020127002892A patent/KR20120081972A/ko not_active Application Discontinuation
- 2010-07-02 WO PCT/EP2010/003946 patent/WO2011000551A1/en active Application Filing
- 2010-07-02 RU RU2012103482/15A patent/RU2012103482A/ru not_active Application Discontinuation
- 2010-07-02 AU AU2010268367A patent/AU2010268367B2/en active Active
- 2010-07-02 BR BRPI1013957A patent/BRPI1013957A2/pt not_active Application Discontinuation
- 2010-07-02 JP JP2012516589A patent/JP2012531391A/ja active Pending
- 2010-07-02 CN CN2010800300523A patent/CN102470167A/zh active Pending
- 2010-07-02 US US13/381,429 patent/US8932855B2/en active Active
- 2010-07-02 EP EP10732289.3A patent/EP2448595B1/en active Active
- 2010-07-02 CN CN201710145377.XA patent/CN107412755A/zh active Pending
-
2011
- 2011-12-14 ZA ZA2011/09226A patent/ZA201109226B/en unknown
- 2011-12-29 IL IL217291A patent/IL217291A0/en unknown
-
2012
- 2012-01-16 IN IN423DEN2012 patent/IN2012DN00423A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US8932855B2 (en) | 2015-01-13 |
JP2012531391A (ja) | 2012-12-10 |
IL217291A0 (en) | 2012-02-29 |
AU2010268367A1 (en) | 2012-01-19 |
WO2011000551A1 (en) | 2011-01-06 |
EP2448595B1 (en) | 2017-06-14 |
EP2448595A1 (en) | 2012-05-09 |
BRPI1013957A2 (pt) | 2016-04-05 |
CA2766833A1 (en) | 2011-01-06 |
CN107412755A (zh) | 2017-12-01 |
ZA201109226B (en) | 2014-05-28 |
US20120183575A1 (en) | 2012-07-19 |
CN102470167A (zh) | 2012-05-23 |
AU2010268367B2 (en) | 2016-10-20 |
KR20120081972A (ko) | 2012-07-20 |
RU2012103482A (ru) | 2013-08-10 |
IN2012DN00423A (es) | 2015-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011013452A (es) | Tratamiento de cancer basado en exosomas. | |
PH12019500289A1 (en) | Vaccines directed against a human enteroviruses | |
AU2018256579A1 (en) | Methods for preparing a skin graft | |
EA201201116A1 (ru) | Моноклональные антитела человека, полученные из в-клеток человека и обладающие нейтрализующей активностью против вирусов гриппа а | |
NZ616304A (en) | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses | |
EA201270173A1 (ru) | Получение полиовируса с высокими титрами для получения вакцины | |
MX342995B (es) | Métodos de generar células asesinas naturales. | |
EA201101111A1 (ru) | Алкиламинозамещенные дицианопиридины и их пролекарства в виде сложных эфиров с аминокислотами | |
EA201291195A1 (ru) | Усовершенствованная терапия рака на основе опухолеассоциированных антигенов, полученных из циклина d1 | |
EA201391170A1 (ru) | Терапевтическое средство на основе дрожжей для лечения хронического гепатита b | |
UA112768C2 (uk) | Європейський штам prrsv | |
MX356210B (es) | Formulaciones de polimero acrilico. | |
NZ603863A (en) | Concentration and lyophilization of influenza vaccine antigens | |
MX2013006758A (es) | Peptidos de union a hla derivados de moleculas antigenicas asociadas a la prostata y metodos de uso de los mismos. | |
IN2014DN07961A (es) | ||
EP2588121A4 (en) | C5A ANALOGUES AND METHODS OF USE THEREOF | |
WO2009135199A3 (en) | Vaccine compositions and methods | |
EA201391396A1 (ru) | Макроциклические соединения и способы их получения | |
MX344544B (es) | Vacuna para paludismo en etapa sanguinea. | |
WO2011109422A8 (en) | Compositions and methods for the treatment of cancer | |
MX348758B (es) | Derivados de sanglifehrina y metodos para su produccion. | |
RU2012127158A (ru) | Способ терапии ремиттирующего рассеянного склероза | |
EA201490725A1 (ru) | Способ лечения мукоэпидермоидной карциномы | |
WO2011006084A3 (en) | Vaccines with oncofetal antigen/ilrp-loaded autologous dendritic cells and uses thereof | |
MY160857A (en) | A cancer vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |